Article

Warburg Pincus completes Lifecore offer

According to affiliates of private equity firm Warburg Pincus, a tender offer for all outstanding shares of Lifecore Biomedical Inc., a medical materials and device maker, is complete.

New York-According to affiliates of private equity firm Warburg Pincus, a tender offer for all outstanding shares of Lifecore Biomedical Inc., a medical materials and device maker, is complete.

The offer, which was worth $17 per share or about $229.5 million, concluded with about 94.2% of outstanding Lifecore shares tendered.

Investments in health care-related companies around the world add up to $6.2 billion for Warburg Pincus, according to the private equity firm, including $2.7 billion in medical device makers such as American Medical Systems, Bausch & Lomb, ev3, Kyphon, Tornier, and Wright Medical Group.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: The role of muscle biopsy in heteroplasmy detection
(Image credit: Ophthalmology Times) AGS 2025: Achieving success as an academic ophthalmologist with Thomas V. Johnson III, MD, PhD
(Image credit: Ophthalmology Times) AGS 2025: Constance Okeke, MD, highlights 1-year Streamline canaloplasty outcomes
(Image credit: Ophthalmology Times) AGS 2025: Telemedicine and genetics for resource-efficient care with Louis R. Pasquale, MD
© 2025 MJH Life Sciences

All rights reserved.